FH and cancer: In the BRCA-positive group, the difference was almost identical; 13.1 MN/1000 (s.e. 2.9; 95% CL 7.2–18.9, P<0.001) between BRCA-positive patients with FH positive and controls (subjects without cancer, BRCA negative and with a negative FH for BC).